Stakeholder Input
Authors
Related Organizations
- Pages
- 248
- Published in
- Canada
CADTH Reimbursement Review - Upadacitinib (Rinvoq) - Sponsor: AbbVie Corporation Therapeutic area: Crohn disease
14 Mar 2024
<Macro 'access_denied_modal'>
<Macro 'unauthorized_modal'>
Add to list
Citation
Health, C., 2024. CADTH Reimbursement Review - Upadacitinib (Rinvoq) - Sponsor: AbbVie Corporation Therapeutic area: Crohn disease, Canadian Agency for Drugs and Technologies in Health.
Canada.
Retrieved from https://coilink.org/20.500.12592/w0vt9zb on 14 Nov 2024. COI: 20.500.12592/w0vt9zb.
Full-page Screenshot
